PRASAD RAJU (Chief Financial Officer) sold 83.8% of their position (34.97K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $2.10M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/26/2026ACC: 0001193125-26-022845
Officer· Chief Financial Officer
Since Mar 2023
-34.97K
Net shares
Net seller
$2.10M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
34.97K acquired · 69.94K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+34.97K
Price / share
$45.15
Trade value
$1.58M
% of position
516.8%
1/22/2026
6.77K→41.74K
Common Shares
Direct
Shares
−34.97K
Price / share
$60.19
Trade value
$2.10M
% of position
83.8%
1/22/2026
41.74K→6.77K
Total
Net shares
+0.00
Net value
-$525.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/22/2026 | M · Option Exercise | +34.97K | $45.15 | $1.58M | 516.8% | 6.77K | 41.74K |
| Common Shares Direct | 1/22/2026 | S · Sale | −34.97K | $60.19 | $2.10M | 83.8% | 41.74K | 6.77K |
| Total | +0.00 | -$525.98K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
34.97K shares
Shares
−34.97K
Strike price
45.15
Held after
41.67K
Exercisable
—
1/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares34.97K shares | 1/22/2026 | M · Option Exercise | −34.97K | 45.15 | — | 41.67K |